Status:
COMPLETED
MEDAM (Menopur Retrospective Data prograM)
Lead Sponsor:
Ferring Pharmaceuticals
Conditions:
Infertility, Female
Eligibility:
FEMALE
18-42 years
Brief Summary
French, non-interventional, retrospective, multicentric analysis of patients who have undergone a controlled ovarian stimulation (COS) for in-vitro fertilization (IVF)/ intracytoplasmic sperm injectio...
Eligibility Criteria
Inclusion
- \- Patient undergoing a COS with HP-hMG for IVF/ICSI cycle from a French data registry between 2009 to 2016
Exclusion
- Ovulation inductions
- Intra-uterine inseminations
- Fertility preservations
- Oocyte donations
Key Trial Info
Start Date :
November 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2021
Estimated Enrollment :
11488 Patients enrolled
Trial Details
Trial ID
NCT04876300
Start Date
November 4 2021
End Date
November 30 2021
Last Update
January 25 2022
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Ferring investigational site
Bondy, France, 93140
2
Ferring investigational site
Clamart, France, 92140
3
Ferring investigational site
Créteil, France, 94010
4
Ferring investigational site
Le Chesnay, France, 78150